Bioiasis AD (XBUL:BIOA) Cyclically Adjusted FCF per Share: €-1.52 (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBUL:BIOA Bioiasis AD XBUL:BIOA
12 GF Score
Price €8.25
! 1 Warning Sign
View Full Analysis

What is Bioiasis AD Cyclically Adjusted FCF per Share?

Bioiasis AD XBUL:BIOA 12 Cyclically Adjusted FCF per Share is €-1.52 as of Sep. 2025. GuruFocus rates XBUL:BIOA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bioiasis AD's adjusted free cash flow per share for the three months ended in Sep. 2025 was €-11.754. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.52 for the trailing ten years ended in Sep. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-10), Bioiasis AD's current stock price is €8.25. Bioiasis AD's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2025 was €-1.52. Bioiasis AD's Cyclically Adjusted Price-to-FCF of today is .


Bioiasis AD  (XBUL:BIOA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bioiasis AD Cyclically Adjusted FCF per Share Related Terms


Bioiasis AD Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Bioiasis AD's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioiasis AD Cyclically Adjusted FCF per Share Chart

Bioiasis AD Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.01 -0.29 -0.27

Bioiasis AD Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -0.28 -0.27 0.00 -1.52

XBUL:BIOA vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Bioiasis AD's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioiasis AD Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioiasis AD's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bioiasis AD's Cyclically Adjusted Price-to-FCF falls into.


XBUL:BIOA
12GF Score
Bioiasis AD XBUL:BIOA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioiasis AD Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bioiasis AD's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2025 (Change)*Current CPI (Sep. 2025)
=-11.754/324.8000*324.8000
=-11.754

Current CPI (Sep. 2025) = 324.8000.

Bioiasis AD Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201509 0.013 237.945 0.018
201512 -0.018 236.525 -0.025
201603 -0.003 238.132 -0.004
201606 0.005 241.018 0.007
201609 0.009 241.428 0.012
201612 0.004 241.432 0.005
201703 0.007 243.801 0.009
201706 0.006 244.955 0.008
201709 0.008 246.819 0.011
201712 -0.013 246.524 -0.017
201803 0.026 249.554 0.034
201806 0.009 251.989 0.012
201809 -0.007 252.439 -0.009
201812 0.005 251.233 0.006
201903 -0.006 254.202 -0.008
201906 -0.006 256.143 -0.008
201909 -0.006 256.759 -0.008
201912 0.001 256.974 0.001
202003 -0.010 258.115 -0.013
202006 -0.001 257.797 -0.001
202009 0.000 260.280 0.000
202012 -0.009 260.474 -0.011
202103 0.003 264.877 0.004
202106 -0.027 271.696 -0.032
202109 -0.001 274.310 -0.001
202112 -0.021 278.802 -0.024
202203 -0.004 287.504 -0.005
202206 0.015 296.311 0.016
202209 -0.010 296.808 -0.011
202212 -0.005 296.797 -0.005
202303 0.002 301.836 0.002
202306 -2.856 305.109 -3.040
202309 -0.217 307.789 -0.229
202312 0.312 306.746 0.330
202403 -0.023 312.332 -0.024
202406 0.147 314.175 0.152
202409 0.006 315.301 0.006
202412 0.111 315.605 0.114
202506 0.000 322.561 0.000
202509 -11.754 324.800 -11.754

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-1.52 mean?
Bioiasis AD (XBUL:BIOA) has a Cyclically Adjusted FCF per Share of €-1.52 as of Sep. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bioiasis AD and its competitors.
Is Bioiasis AD's Cyclically Adjusted FCF per Share too high?
Bioiasis AD's current Cyclically Adjusted FCF per Share is €-1.52. Overall, Bioiasis AD has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioiasis AD's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Bioiasis AD's Cyclically Adjusted FCF per Share of €-1.52 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bioiasis AD and its competitors. Bioiasis AD's current Cyclically Adjusted FCF per Share is €-1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioiasis AD stock overvalued right now?
Bioiasis AD (XBUL:BIOA) has a current Cyclically Adjusted FCF per Share of €-1.52. The current Cyclically Adjusted FCF per Share is €-1.52. Bioiasis AD's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Bioiasis AD (XBUL:BIOA), the current Cyclically Adjusted FCF per Share is €-1.52 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioiasis AD Business Description

Address 60, Deyan Belishki Str., Ground Floor, Sofia, BGR, 1404
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.
12GF Score

Get the complete analysis for XBUL:BIOA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.25
Price